Evidence map›Paper›PMID 38023417›Full record

ArticleResearch (Washington, D.C.)2023

Interindividual Age-Independent Differences in Human CX43 Impact Ventricular Arrhythmic Risk.

Laura García-Mendívil, María Pérez-Zabalza, Antoni Oliver-Gelabert, José María Vallejo-Gil, Javier Fañanás-Mastral, Manuel Vázquez-Sancho, Javier André Bellido-Morales, Alexánder Sebastián Vaca-Núñez, Carlos Ballester-Cuenca, Emiliano Diez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Research (Washington, D.C.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Research progress of connexin 43 in cardiovascular diseases.Frontiers in cardiovascular medicine · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Laura García-MendívilBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza 50018, Spain.ORCID https://orcid.org/0000-0002-2954-1068
María Pérez-ZabalzaBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza 50018, Spain.ORCID https://orcid.org/0000-0002-3194-7796
Antoni Oliver-GelabertBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza 50018, Spain.ORCID https://orcid.org/0000-0001-8571-2733
José María Vallejo-GilDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza 50009, Spain.
Javier Fañanás-MastralDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza 50009, Spain.
Manuel Vázquez-SanchoDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza 50009, Spain.
Javier André Bellido-MoralesDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza 50009, Spain.
Alexánder Sebastián Vaca-NúñezDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza 50009, Spain.
Carlos Ballester-CuencaDepartment of Cardiovascular Surgery, University Hospital Miguel Servet, Zaragoza 50009, Spain.
Emiliano DiezInstitute of Experimental Medicine and Biology of Cuyo (IMBECU), CONICET, Mendoza 5500, Argentina.ORCID https://orcid.org/0000-0001-5163-3703
Laura OrdovásBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza 50018, Spain.ORCID https://orcid.org/0000-0003-3982-1263
Esther PueyoBiomedical Signal Interpretation and Computational Simulation group (BSICoS), Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza 50018, Spain.ORCID https://orcid.org/0000-0002-1960-407X
Hospital Universitario Miguel Servet · ESUniversidad de Zaragoza · ESConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Connexin 43 (CX43) is one of the major components of gap junctions, the structures responsible for the intercellular communication and transmission of the electrical impulse in the left ventricle. There is limited information on the histological changes of CX43 with age and their effect on electrophysiology, especially in humans. Here, we analyzed left ventricular biopsies from living donors starting at midlife to characterize age-related CX43 remodeling. We assessed its quantity, degree of lateralization, and spatial heterogeneity together with fibrotic deposition. We observed no significant age-related remodeling of CX43. Only spatial heterogeneity increased slightly with age, and this increase was better explained by biological age than by chronological age. Importantly, we found that CX43 features varied considerably among individuals in our population with no relevant relationship to age or fibrosis content, in contrast to animal species. We used our experimental results to feed computational models of human ventricular electrophysiology and to assess the effects of interindividual differences in specific features of CX43 and fibrosis on conduction velocity, action potential duration, and arrhythmogenicity. We found that larger amounts of fibrosis were associated with the highest arrhythmic risk, with this risk being increased when fibrosis deposition was combined with a reduction in CX43 amount and/or with an increase in CX43 spatial heterogeneity. These mechanisms underlying high arrhythmic risk in some individuals were not associated with age in our study population. In conclusion, our data rule out CX43 remodeling as an age-related arrhythmic substrate in the population beyond midlife, but highlight its potential as a proarrhythmic factor at the individual level, especially when combined with increased fibrosis.

Identifiers

PMID38023417
PMCPMC10650968
OpenAlexW4387653112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.